MVIS - Microvision Inc
Executive Summary
MicroVision Inc (MVIS) is a US-listed technology company that develops advanced perception solutions based on its proprietary lidar and sensing technology. Its products target industrial, security and autonomy applications, where the company positions itself as a specialist supplier of perception hardware and software to OEMs and systems integrators.
The investment case rests on the conversion of an existing Master Development Agreement (MDA) with a major OEM into a recurring supply contract, alongside maintenance of full-year 2026 revenue guidance of approximately USD 10 million. The principal risk is the company's high cash burn, reported in the analyst reasoning at roughly USD 60 million per annum, which may necessitate additional dilutive financing before commercial volumes scale.
OPPORTUNISTIC BUY. Conviction Score: 59/100. The view would shift higher on confirmation of a multi-unit supply agreement with the OEM counterparty to the MDA, and lower if quarterly results point to a material widening of the cash burn or to slippage in converting development agreements into purchase orders.
Thesis break: The thesis would be invalidated by a public statement that the major OEM MDA will not convert into a supply agreement, by revenue guidance being withdrawn or cut materially below the USD 10 million 2026 target, or by a deeply dilutive equity raise undertaken at a substantial discount to the prevailing share price.
Business Model
MicroVision generates revenue primarily through the sale, licensing and development of lidar and related perception hardware, with associated software and engineering services. Customers are principally OEMs and systems integrators operating in industrial automation, security and adjacent autonomy verticals, where the company's MEMS-based scanning technology is integrated into end-customer products.
In the second quarter of 2026, the company reported revenue of approximately USD 1.5 million, a year-on-year increase driven by development and sampling activity rather than volume production. Reported gross margin for the quarter was 44%, indicating that the current revenue mix is broadly contribution-positive on a unit basis even at low volumes, although absolute gross profit remains small relative to the operating cost base.
The competitive moat is built around MicroVision's proprietary MEMS scanning platform and accumulated lidar patent portfolio, which together create a degree of technological differentiation against pure-play competitors. However, the moat is narrow at present because revenue is concentrated in low-volume development programmes and the company has not yet demonstrated scaled production economics; commercial traction with at least one major OEM is therefore the principal determinant of forward earnings power.
Financial Snapshot
Recent Catalysts
[Q2 2026 / 6 August 2026] - MicroVision announced second quarter 2026 financial and operating results and reported revenue of USD 1.5 million at a 44% gross margin, alongside maintenance of full-year 2026 revenue guidance of approximately USD 10 million. Source: MicroVision, Inc. press release (ir.microvision.com).
[5 August 2026] - A pre-results press notice was issued referencing the upcoming second quarter 2026 results call scheduled for 6 August 2026. Source: MicroVision, Inc. investor relations (ir.microvision.com).
[15 July 2026] - A company press release dated 15 July 2026 was published on the MicroVision investor relations news page, indicative of continued commercial momentum disclosures across multiple markets. Source: MicroVision, Inc. investor relations (ir.microvision.com).
[Q1 2026 / March 2026] - The company reported its first quarter 2026 results, with Investing.com noting that MicroVision earnings beat expectations although revenue fell short of consensus estimates. Source: Investing.com earnings coverage.
[2026 to date] - A Master Development Agreement with a major OEM has been signed, providing the hard catalyst underpinning the current investment thesis and validating commercial traction in autonomous industrial applications. Source: Analyst reasoning referencing the signed MDA.
Thesis Evaluation
Bull Case (26% weight)
The MDA with the major OEM converts into a multi-unit supply agreement during 2026-2027, with at least one further OEM signing a development or supply contract, allowing MicroVision to scale towards its USD 10 million 2026 revenue target and begin to absorb its roughly USD 60 million annual cost base. On this outcome a 12-month price target of 8.50 is plausible.
Base Case (49% weight)
MicroVision maintains revenue near its guided USD 10 million for 2026, executes modestly on the existing MDA without a major follow-on supply contract, and continues to fund the cash burn through a combination of existing reserves and modest non-dilutive or limited dilutive financing. On this outcome a 12-month price target of 4.80 is the most realistic base case.
Bear Case (25% weight)
The MDA fails to convert into a supply contract, revenue stalls well below the USD 10 million guide, and the company is forced into a sizeable dilutive equity raise to sustain operations given the roughly USD 60 million annual cash burn. On this outcome a 12-month downside target of 1.80 is the realistic floor.
Key Risks
- Cash burn and dilution risk: Annual cash burn of roughly USD 60 million against low single-digit million quarterly revenue creates a structural funding gap that may require further dilutive equity issuance. Estimated probability: 60%. Impact: severe.
- MDA conversion risk: The Master Development Agreement with the major OEM may fail to translate into a recurring supply contract, removing the principal hard catalyst underpinning the thesis. Estimated probability: 45%. Impact: severe.
- Customer concentration risk: Revenue and forward pipeline appear concentrated around a small number of OEM and integrator relationships, leaving the top line vulnerable to programme delays or cancellations by individual counterparties. Estimated probability: 50%. Impact: moderate.
- Competitive risk in lidar: MicroVision operates in a competitive lidar market with well-capitalised peers pursuing alternative scanning architectures, which could erode pricing power and design-win share over time. Estimated probability: 40%. Impact: moderate.
- Liquidity and going-concern risk: If revenue underperforms guidance or a financing window closes, there is a credible risk that the company would need to disclose material uncertainty regarding its ability to continue as a going concern within a 12-month horizon. Estimated probability: 25%. Impact: severe.
Who Should Own It / Avoid It
Ideal for: Speculative growth investors with a minimum 18-24 month holding horizon, a high tolerance for equity volatility and drawdowns, and the capacity to absorb a potentially dilutive financing event; the position should be sized as a satellite holding rather than a core allocation given the negative free cash flow profile.
Avoid if: Investors requiring current income, those with a low tolerance for dilution, or any investor whose mandate prohibits holdings in pre-profit companies with persistent negative free cash flow and concentrated customer pipelines should avoid MVIS, as the path to profitability is unproven and interim capital raises are likely.
Recommendation
OPPORTUNISTIC BUY - 59/100. The recommendation reflects a hard commercial catalyst in the form of a signed MDA with a major OEM, which validates near-term commercial traction, balanced against a structurally negative free cash flow profile and the likelihood of further capital raises. An upgrade to a higher conviction tier would require confirmation of a multi-unit supply agreement under the MDA and evidence that 2026 revenue is tracking at or above the USD 10 million guidance; a downgrade would be triggered by MDA slippage, a revenue warning, or a deeply dilutive equity issuance that materially impairs per-share value. At the current price of $3.72 the shares trade above our buy ceiling of $2.80: the thesis is credible but the price is not - new positions only below that level.
The probability-weighted value across our three scenarios is $5.01, 35% above the current price of $3.72 - the market has not yet priced our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.
below $2.80 - below this level the upside to the base-case target ($4.80) is at least 2x the downside to the bear case ($1.80), the minimum risk/reward we require before committing new capital.
between $2.80 and $4.80 - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.
above $4.80 - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 26%.
if the thesis would be invalidated by a public statement that the major OEM MDA will not convert into a supply agreement, by revenue guidance being withdrawn or cut materially below the USD 10 million 2026 target, or by a deeply dilutive equity raise undertaken at a substantial discount to the prevailing share price, regardless of price - the bear target of $1.80 is the backstop, not an arbitrary percentage stop.
Conviction Trend
Latest conviction: 59/100. Trend versus prior report: Initiation.
| Report date | Conviction |
|---|---|
| 2026-08-11 | 59 |
Sources
Market data: DYOR HQ proprietary market data workflow.
Public sentiment and news flow: Public news flow, company earnings releases and presentations, regulatory filings, investor day and investor relations materials, and third-party financial news and analyst commentary covering the second quarter 2026 results period and prior 2026 reporting periods.
Primary source types: SEC filings, earnings call transcripts, company press releases, company investor relations materials, regulatory announcements, and third-party research drawn from public financial news wires and analyst commentary.
Key sources
- Microvision (MVIS) Earnings Date and Reports 2026 $MVIS
- MicroVision, Inc. Common Stock (MVIS) Earnings Report Dates & Earnings Forecasts | Nasdaq
- MicroVision, Inc. (MVIS) Stock Price, News, Quote & History - Yahoo Finance
- News :: MicroVision, Inc. (MVIS)
- Microvision Inc (MVIS) (Q2 2026) Earnings Call Highlights: Revenue Surges 650% as Gross Margin ...
- MicroVision Signs Long-Term Development Agreement to Advance Lidar for Next-Generation Autonomous Hauling Solutions :: MicroVision, Inc. (MV
- MicroVision Signs Long-Term Development Agreement to Advance Lidar for Next-Generation Autonomous Hauling Solutions | Morningstar
- MicroVision Inc. - Plans of Reorganization, Merger, Acquisition or Similar - BamSEC
- Microvision (MVIS) Stock Forums - Investing.com
- MicroVision (MVIS) Stock Forecast & Analyst Price Targets
Data correct as of 2026-08-11